All News about Zomedica Pharmaceuticals Corp
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
June 13, 2022
From Zomedica Corp.
Via AccessWire
Topics
Law Enforcement
Exposures
Legal
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://www.issuerdirect.com/images/AW-ISDR-ICON.png)
From Traders News Source
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://cdn.benzinga.com/files/images/story/2022/05/11/1_3.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7522.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_6041.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_7415.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/muln-1600-2.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://investorplace.com/wp-content/uploads/2021/04/zom-stock-1.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
From Zomedica Corp.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/29220.png?v=1)
Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin
February 25, 2022
From Zomedica Corp.
Via AccessWire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2075.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.